Business & Finance
Institute of Pathology Heidelberg Joins Thermo Fisher Scientific Center of Excellence Programm
8 September 2017 - - US-based life science company Thermo Fisher Scientific has signed an agreement with the Institute of Pathology Heidelberg to establish its Center of Molecular Pathology at Heidelberg University Hospital as the newest member of the Next Generation Sequencing Companion Dx Center of Excellence Program, the company said.

The initiative focuses on forging strategic collaborations with leading, European-based organizations that can lead studies using Thermo Fisher's Oncomine portfolio of research panels destined for development as companion diagnostics to help drive precision oncology in the region.

Working in collaboration with pharmaceutical partners and Thermo Fisher, the IPH Center of Molecular Pathology, headed by Dr. Albrecht Stenzinger, will conduct studies and clinical trials under a leadership of Professor Peter Schirmacher, director of the Institute of Pathology of Heidelberg University Hospital.

Leaders in their field, Stenzinger and his team have in-depth expertise with Thermo Fisher's next-generation sequencing platforms and various gene panels, which they use to profile in clinical trials across several cancer types and more than 3,500 samples in clinical diagnostics annually.

The Institute is also the site of Germany's largest tissue biobank, featuring a sophisticated laboratory information management system that has incorporated Thermo Fisher's Ion Torrent bioinformatics software.

Coupled with its biomarker development and translational diagnostics program, the IPH is uniquely positioned as an ideal Thermo Fisherpartner to develop NGS-based diagnostics.

Heidelberg University Hospital is one of the largest medical centers in Europe with its unique campus site shared with the German Cancer Research Center. It is characterized by its pursuit of developing innovative methods in diagnosis and treatment, while its clinical research arm has long been an early adopter of leading technology.

The IPH Center of Molecular Pathology is the second organization to join the COEP after the Institute of Medical Genetics and Pathology at University Hospital Basel, which joined in April.

Thermo Fisher Scientific in serving science, with revenues of more than USD 20bn and approximately 65,000 employees globally.

The company's brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.